Literature DB >> 1889699

Complications of endoscopic sphincterotomy. A prospective series with emphasis on the increased risk associated with sphincter of Oddi dysfunction and nondilated bile ducts.

S Sherman1, T A Ruffolo, R H Hawes, G A Lehman.   

Abstract

Mostly retrospective series with limited use of sphincter of Oddi manometry have indicated that early complications are more common when endoscopic sphincterotomy is performed for sphincter of Oddi dysfunction than for common duct stones. The current study was undertaken to prospectively evaluate the frequency and type of complications of endoscopic sphincterotomy performed for sphincter of Oddi dysfunction compared with endoscopic sphincterotomy performed for other conditions. Four hundred twenty-three patients underwent sphincterotomy for sphincter of Oddi dysfunction (166), common duct stone(s) (163), tumor (60), and miscellaneous reasons (34). Patients were observed in the hospital for at least 24 hours after the procedure, and 30-day follow-up data were obtained. The overall complication rate was 6.9%, but complications were more frequent when sphincterotomy was performed for sphincter of Oddi dysfunction than for all other indications (10.8% vs. 4.3%; P = 0.009). Precut sphincterotomy was more frequently required in the sphincter of Oddi dysfunction group (21.1% vs. 11.7%, P = 0.009) but was no more likely to result in a complication (6.2%) than standard sphincterotomy. The risk of a complication was considerable for a small-diameter common bile duct (less than or equal to 5 mm), particularly when sphincterotomy was performed for sphincter of Oddi dysfunction (37.5%). The overall 30-day mortality rate was 1.7%, but the procedure-related mortality rate was believed to be 0.2%. It is concluded that endoscopic sphincterotomy for sphincter of Oddi dysfunction is more hazardous than for other conditions, particularly when a small common bile duct is present.

Entities:  

Mesh:

Year:  1991        PMID: 1889699

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  88 in total

Review 1.  Precut sphincterotomy: indications, pitfalls, and complications.

Authors:  C J Larkin; K Huibregtse
Journal:  Curr Gastroenterol Rep       Date:  2001-04

Review 2.  Biliary tract imaging.

Authors:  E Corazziari
Journal:  Curr Gastroenterol Rep       Date:  1999-04

Review 3.  Efficacy of biliary scintigraphy in suspected sphincter of Oddi dysfunction.

Authors:  S Jagannath; A N Kalloo
Journal:  Curr Gastroenterol Rep       Date:  2001-04

4.  ERCP-induced Pancreatitis.

Authors: 
Journal:  Curr Treat Options Gastroenterol       Date:  2000-10

5.  Intravenous bolus somatostatin after diagnostic cholangiopancreatography reduces the incidence of pancreatitis associated with therapeutic endoscopic retrograde cholangiopancreatography procedures: a randomised controlled trial.

Authors:  R T-P Poon; C Yeung; C-L Liu; C-M Lam; W-K Yuen; C-M Lo; A Tang; S-T Fan
Journal:  Gut       Date:  2003-12       Impact factor: 23.059

6.  Diagnostic and therapeutic ERCP: a large single centre's experience.

Authors:  R J Farrell; N Mahmud; N Noonan; D Kelleher; P W Keeling
Journal:  Ir J Med Sci       Date:  2001 Jul-Sep       Impact factor: 1.568

7.  The burden of endoscopic retrograde cholangiopancreatography (ERCP) performed with the patient under conscious sedation.

Authors:  S M Jeurnink; E W Steyerberg; E J Kuipers; P D Siersema
Journal:  Surg Endosc       Date:  2012-08       Impact factor: 4.584

Review 8.  Balloon dilation itself may not be a major determinant of post-endoscopic retrograde cholangiopancreatography pancreatitis.

Authors:  Sung Ill Jang; Gak Won Yun; Dong Ki Lee
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

9.  Endoscopic sphincterotomy for stenosis of the sphincter of Oddi.

Authors:  C Sugawa; D H Park; C E Lucas; D Higuchi; K Ukawa
Journal:  Surg Endosc       Date:  2001-07-05       Impact factor: 4.584

10.  Prophylactic effect of glyceryl trinitrate on post-endoscopic retrograde cholangiopancreatography pancreatitis: a randomized placebo-controlled trial.

Authors:  Jian Yu Hao; Dong Fang Wu; Yue Zeng Wang; Ying Xin Gao; Hai Po Lang; Wei Zhen Zhou
Journal:  World J Gastroenterol       Date:  2009-01-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.